IMUNON, Inc. announced on October 7, 2024, the appointment of Susan Eylward as General Counsel and Corporate Secretary, effective the same day. Ms. Eylward brings experience from her previous role as Senior Counsel at Science 37, Inc., where she managed complex legal matters including corporate governance and securities compliance.
In connection with her appointment, Ms. Eylward received inducement stock options to purchase 50,000 shares of the company's common stock. These options were granted in accordance with Nasdaq Listing Rule 5635(c)(4) as a material inducement for her employment.
The options have an exercise price equal to the closing price of IMUNON's common stock on October 7, 2024, a 10-year term, and a four-year vesting schedule. This addition to the leadership team is intended to strengthen the company's operational excellence and support its future plans.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.